πŸ‡ΊπŸ‡Έ FDA
Patent

US 11629167

Betulastatin compounds

granted A61KA61K31/56A61P

Quick answer

US patent 11629167 (Betulastatin compounds) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/56, A61P, A61P29/00, A61P35/00